MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 107 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $143 | -93.2% | 71,506 | -84.8% | 0.00% | -100.0% |
| Q1 2024 | $2,099 | +415.7% | 468,923 | +166.7% | 0.01% | +250.0% |
| Q4 2023 | $407 | -9.4% | 175,808 | -50.3% | 0.00% | 0.0% |
| Q3 2023 | $449 | -100.0% | 354,075 | +174.8% | 0.00% | -84.6% |
| Q2 2020 | $3,016,000 | +162.9% | 128,860 | -34.6% | 0.01% | +85.7% |
| Q1 2020 | $1,147,000 | +54.6% | 196,888 | +51.9% | 0.01% | +133.3% |
| Q4 2019 | $742,000 | +363.8% | 129,596 | +27.6% | 0.00% | +200.0% |
| Q3 2019 | $160,000 | -21.6% | 101,595 | +101.9% | 0.00% | 0.0% |
| Q2 2019 | $204,000 | +16.6% | 50,317 | +353.9% | 0.00% | 0.0% |
| Q1 2018 | $175,000 | – | 11,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |